A 35-year-old intravenous drug user develops fever, chills, and a new murmur of tricuspid regurgitation. Blood cultures grow Staphylococcus aureus. Echocardiography confirms vegetation on the tricuspid valve. He has no left-sided vegetations. Duke criteria — major: 2 positive blood cultures for S. aureus, new valvular regurgitation. The diagnosis is definite IE. Per current guidelines, what is the MINIMUM duration of IV antibiotic therapy?
- A 4–6 weeks of IV antistaphylococcal therapy (oxacillin for MSSA, vancomycin for MRSA)
- B 6–8 weeks of combination therapy with gentamicin added to penicillin
- C 14 days of IV therapy followed by oral step-down to trimethoprim-sulfamethoxazole
- D 2 weeks of IV therapy is acceptable for uncomplicated right-sided S. aureus IE in PWID if specific criteria met ✓
Explanation
The ESC 2023 and AHA 2015 guidelines allow a 2-week shortened course of IV antibiotic therapy for uncomplicated right-sided S. aureus native valve endocarditis in persons who inject drugs (PWID), provided specific criteria are met: (1) MSSA (methicillin-sensitive), (2) no pulmonary complications, (3) no left-sided involvement, (4) no evidence of septic emboli, (5) no renal impairment, and (6) rapid response to therapy. This 2-week regimen (using nafcillin/oxacillin or even daptomycin for right-sided MSSA IE) has been validated in trials and is recommended to facilitate earlier hospital discharge and reduce complications of prolonged IV access in this population. Left-sided S. aureus IE requires 6 weeks. Gentamicin is no longer routinely recommended for staphylococcal IE due to nephrotoxicity.
Reference: Harrison's Principles of Internal Medicine, 21st ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.